Your new experience awaits. Try the new design now and help us make it even better

EDITORIAL article

Front. Neurosci.

Sec. Neurodegeneration

Volume 19 - 2025 | doi: 10.3389/fnins.2025.1635008

This article is part of the Research TopicProgress in Neuroacanthocytosis Syndromes and Related Diseases Including other Bulk Lipid Transfer DisordersView all 11 articles

Editorial: Progress in Neuroacanthocytosis Syndromes and Related Diseases Including Other Bulk Lipid Transfer Disorders

Provisionally accepted
  • 1Ludwig-Maximilians-Universitat Munchen, Munich, Germany
  • 2Universitatsmedizin Rostock, Rostock, Germany
  • 3Medical School, Saarland University, Saarbrücken, Germany
  • 4Universitat de Barcelona, Barcelona, Spain
  • 5Icahn School of Medicine at Mount Sinai, New York, United States

The final, formatted version of the article will be published soon.

The rare conditions XK disease (McLeod syndrome) and VPS13A disease (chorea-acanthocytosis), 25 have historically been termed "neuroacanthocytosis", due to the association of neurodegeneration, 26 particularly of the basal ganglia, with spiky deformed red blood cells (acanthocytes). Even more 27 obsolete is the 1960s' designation "Levine-Critchley syndrome": genetic analyses of the reported 28 families have determined that Levine´s patients were affected by mutations of XK and those of 29Critchley by VPS13A variants. Two multi-author books summarize early developments (Danek,30 2004; The articles collected here represent a number of recent advances in this rapidly-evolving field. The 94 ultimate goal is to develop and validate therapies for these devasting neurological and multi-organ 95 disorders, and additionally to add to understanding of cellular processes which may benefit other 96 fields. 97

Keywords: BLTP, VPS13, XK, neurodegeneration, neurodevelopment, Neuroacanthocytosis

Received: 25 May 2025; Accepted: 28 May 2025.

Copyright: © 2025 Danek, Hermann, Kaestner, Masana, Peikert, Rodriguez and Walker. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lars Kaestner, Medical School, Saarland University, Saarbrücken, 66421, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.